The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
Subscribe To Our Newsletter & Stay Updated
